Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Rule 14a-11-Miles
4
Feb 10, 2011 06:36PM
6
Feb 10, 2011 06:49PM
6
Feb 10, 2011 06:56PM
5
Feb 10, 2011 07:18PM
7
Feb 10, 2011 07:34PM
3
Feb 10, 2011 07:54PM
5
Feb 10, 2011 08:25PM
11
Feb 11, 2011 06:02AM
5
Feb 11, 2011 06:41AM
6
Feb 11, 2011 10:02AM
10
Feb 11, 2011 10:33AM

The way I read SEC rule 14a-11 it's going to be three years before any shareholder nominee can be included by right on the proxy, but I'm sure there will be many who disagree.

You raise an interesting point regarding a three member BoD coupled with the 25% limit. As a nominee would be attempting to replace 33%, would the nomination be allowed?

However, they will use our money to pay for an attorney to fight that effort just as they did with Pete Lozano

I believe you'll find that the nomination was ineligible from the outset and all the money expended was a waste of Company resources in having to prove such. It only has to be hoped that further resources aren't wasted on even more frivolous nominations.

.

.

.

Be well

10
Feb 11, 2011 11:23AM
5
Feb 11, 2011 11:40AM

Feb 11, 2011 11:55AM
Share
New Message
Please login to post a reply